NCT01200862 Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal Men Status TERMINATED Phase PHASE2
NCT01199861 Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS) Status COMPLETED Phase PHASE3
NCT01197040 Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome Status COMPLETED Phase PHASE3
NCT01196546 Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE4
NCT01194908 Re-expression of ER in Triple Negative Breast Cancers Status TERMINATED Phase PHASE1/PHASE2
NCT01193907 Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old) Status COMPLETED Phase PHASE2
NCT01190475 BGS649 Monotherapy in Moderate to Severe Endometriosis Patients Status COMPLETED Phase PHASE2
NCT01188889 RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease. Status WITHDRAWN Phase PHASE1/PHASE2
NCT01185990 Tinnitus Measured by MEG and Synchronous Neural Interaction™ Test: Template Development Status UNKNOWN Phase N/A
NCT01185366 Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma Status TERMINATED Phase PHASE2
NCT01184326 Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer Status COMPLETED Phase PHASE1
NCT01183247 An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens Status COMPLETED Phase PHASE4
NCT01181713 Change in Ocular Flora Resistance From Repeated Topical Antibiotic Use Status COMPLETED Phase N/A
NCT01175096 Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor Status UNKNOWN Phase PHASE1/PHASE2
NCT01174888 Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT01169636 Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2